(Q39108160)

9 September 2017

title

Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL. (English)

1 reference

glucocorticoid resistance

9 September 2017

main subject

1 reference

inferred from title

author name string

J A P Spijkers-Hagelstein

1

1 reference

9 September 2017

S S Pinhanços

2

1 reference

9 September 2017

P Schneider

3

1 reference

9 September 2017

R Pieters

4

1 reference

9 September 2017

R W Stam

5

1 reference

9 September 2017

publication date

20 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

28

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

761-769

1 reference

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

The Connectivity Map: a new tool for biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.245

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

Infant leukaemia biology, aetiology and treatment

1 reference

12 December 2020

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.

1 reference

12 December 2020

Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)

1 reference

12 December 2020

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways

1 reference

12 December 2020

In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group

1 reference

12 December 2020

The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells

1 reference

12 December 2020

Synergy, additivism and antagonism in immunosuppression. A critical review

1 reference

12 December 2020

Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.

1 reference

12 December 2020

Acute lymphoblastic leukemia

1 reference

12 December 2020

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

1 reference

12 December 2020

Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy

1 reference

12 December 2020

Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.245

1 reference

Dimensions Publication ID

9 September 2017

1026911334

0 references

1 reference